Top

Indian Journal of Thoracic and Cardiovascular Surgery

Published in:

01-01-2018 | Review Article

Surgery for mesothelioma: the evidence base and a pragmatic approach to surgical treatment

Authors: Vasudev Baburaya Pai, Kandadai Seshadri Rammohan, Tom Treasure

Published in: Indian Journal of Thoracic and Cardiovascular Surgery | Special Issue 1/2018

Abstract

The authors were invited to provide a summary of the current evidence and an evidence-based approach to practice. Clinical practice guidelines are not available for India and a formal approach to these would require a properly constituted guideline development group rather than an opinion piece from three surgeons. What we have provided is a critical view of current practice and some pointers to a realistic pragmatic approach intended to avoid non-evidence-based practice and excessive harm to no advantage.

https://www.google.co.uk/search?source=hp&q=australian+meso+guidelines&oq=australian+meso+guidelines&gs_l=psy-ab.3...2553.15894.0.18503.35.30.4.0.0.0.119.2593.27j3.30.0....0...1.1.64.psy-ab..1.33.2522.0..0j35i39k1j0i131k1j0i10k1j0i13k1j0i22i30k1j33i160k1j33i21k1.0.tN6ZgsTa9no

http://timesofindia.indiatimes.com/home/environment/pollution/NGT-asks-5-mineral-rich-states-to-survey-all-asbestos-mines/articleshow/48039145.cms April 2016 accessed August 2017.

van Zandwijk N, Clarke C, Henderson D, et al. Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. J Thorac Dis. 2013;5:E254–307.

Gilham C, Rake C, Burdett G, et al. Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden. Occup Environ Med. 2016;73:290–9.

Rake C, Gilham C, Hatch J, Darnton A, Hodgson J, Peto J. Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. Br J Cancer. 2009;100:1175–83.

Okello C, Treasure T, Nicholson AG, Peto J, Moller H. Certified causes of death in patients with mesothelioma in South East England. BMC Cancer. 2009;9:28.

Bruni BM, Pacella A, MazziottiTagliani S, Gianfagna A, Paoletti L. Nature and extent of the exposure to fibrous amphiboles in Biancavilla. Sci Total Environ. 2006;370:9–16.

Proietti L, Migliore M, Polosa R, Comba P, Circo C, Di Maria GU. Malignant pleural mesothelioma in housewives in the province of Catania. Recenti Prog Med. 2004;95:365–8.

Yamashita Y, Harada H, Mukaida H, Kaneko M. Extrapleural pneumonectomy plus rib resection for malignant pleural mesothelioma: a case report. J Cardiothorac Surg. 2014;9:176.

Patel SC, Dowell JE. Modern management of malignant pleural mesothelioma. Lung Cancer (Auckl). 2016;7:63–72.

Taioli E, Wolf AS, Camacho-Rivera M, et al. Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients. PLoS One. 2015;10:e0145039.

10.

Rice D, Rusch V, Pass H, et al. Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group. J Thorac Oncol. 2011;6:1304–12.

11.

Hasani A, Alvarez JM, Wyatt JM, et al. Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia. J Thorac Oncol. 2009;4:1010–6.

12.

Sugarbaker DJ. Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma. J Thorac Oncol. 2006;1:175–6.

13.

Sugarbaker DJ, Garcia JP, Richards WG, et al. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg. 1996;224:288–94.

14.

Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999;117:54–63.

15.

Sugarbaker DJ, Jaklitsch MT, Bueno R, et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg. 2004;128:138–46.

16.

Stewart DJ, Martin-Ucar A, Pilling JE, Edwards JG, O'Byrne KJ, Waller DA. The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma. Ann Thorac Surg. 2004;78:245–52.

17.

Waller DA. Malignant mesothelioma-British surgical strategies. Lung Cancer. 2004;45:S81–4.

18.

Stewart DJ, Martin-Ucar AE, Edwards JG, West K, Waller DA. Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations. Eur J Cardiothorac Surg. 2005;27:373–8.

19.

Treasure T, Sedrakyan A. Pleural mesothelioma: little evidence, still time to do trials. Lancet. 2004;364:1183–5.

20.

Treasure T, Waller D, Tan C, et al. The Mesothelioma and Radical surgery randomized controlled trial: the Mars feasibility study. J Thorac Oncol. 2009;4:1254–8.

21.

Cao CQ, Yan TD, Bannon PG, McCaughan BC. A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Oncol. 2010;5:1692–703.

22.

Flores RM, Zakowski M, Venkatraman E, et al. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center. J Thorac Oncol. 2007;2:957–65.

23.

Utley M, Fiorentino F, Treasure T. Obtaining an upper estimate of the survival benefit associated with surgery for mesothelioma. Eur J Cardiothorac Surg. 2010;38:241–4.

24.

Treasure T, Lang-Lazdunski L, Waller D, et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol. 2011;12:763–72.

25.

Weder W, Stahel RA, Baas P, et al. The MARS feasibility trial: conclusions not supported by data. Lancet Oncol. 2011;12:1093–4.

26.

Rusch V, Baldini EH, Bueno R, et al. The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: Meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass. J Thorac Cardiovasc Surg. 2013;145:909–10.

27.

Bliss JM, Coombes G, Darlison L, et al. The MARS feasibility trial: correspondence. Lancet Oncol. 2011;12:1094–5.

28.

Treasure T, Utley M, O'Byrne K. MARS: a sense of perspective and an inconvenient truth. J Thorac Oncol. 2013;8:e48–9.

29.

Hiddinga BI, van Meerbeeck JP. Surgery in mesothelioma - where do we go after MARS? J Thorac Oncol. 2013;8:525–9.

30.

Lee YC. Surgical resection of mesothelioma: an evidence-free practice. Lancet. 2014;384:1080–1.

31.

Bovolato P, Casadio C, Bille A, et al. Does surgery improve survival of patients with malignant pleural mesothelioma?: a multicenter retrospective analysis of 1365 consecutive patients. J Thorac Oncol. 2014;9:390–6.

32.

Rena O, Casadio C. Lack of evidence in malignant pleural mesothelioma surgery. Interact Cardiovasc Thorac Surg. 2011;12:347–8.

33.

Rena O, Casadio C. Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: A harmful procedure. Lung Cancer. 2012;77:151–5.

34.

Rusch VW, Giroux D, Kennedy C, et al. Initial analysis of the international association for the study of lung cancer mesothelioma database. J Thorac Oncol. 2012;7:1631–9.

35.

Batirel HF, Metintas M, Caglar HB, et al. Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy. J Thorac Cardiovasc Surg. 2016;151:478–84.

36.

Azzouqa AG, Stevenson JP. The evolution of the diminishing role of extrapleural pneumonectomy in the surgical management of malignant pleural mesothelioma. Onco Targets Ther. 2016;9:7247–52.

37.

Treasure T, Macbeth F. An exception that proves the rule: recurrence free survival five years after extrapleural pneumonectomy for malignant pleural mesothelioma. J Cardiothorac Surg. 2014;9:181.

38.

Flores RM, Pass HI, Seshan VE, et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg. 2008;135:620–6.

39.

Lang-Lazdunski L, Bille A, Lal R, et al. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma. J Thorac Oncol. 2012;7:737–43.

40.

Cao C, Tian D, Park J, Allan J, Pataky KA, Yan TD. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma. Lung Cancer. 2014;83:240–5.

41.

Burt BM, Cameron RB, Mollberg NM, et al. Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality. J Thorac Cardiovasc Surg. 2014;148:30–5.

42.

Taioli E, Wolf AS, Flores RM. Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma. Ann Thorac Surg. 2015;99:472–80.

43.

Teh E, Fiorentino F, Tan C, Treasure T. A systematic review of lung-sparing extirpative surgery for pleural mesothelioma. J R Soc Med. 2011;104:69–80.

44.

Flores RM. Pleurectomy decortication for mesothelioma: The procedure of choice when possible. J Thorac Cardiovasc Surg. 2016;151:310–2.

45.

Flores RM. The mesothelioma surgery shift. J Thorac Cardiovasc Surg. 2016;151:485–6.

46.

Flores RM. The mesothelioma enigma. J Thorac Cardiovasc Surg. 2015;149:1548–9.

47.

Cao C, Tian DH, Pataky KA, Yan TD. Systematic review of pleurectomy in the treatment of malignant pleural mesothelioma. Lung Cancer. 2013;81:319–27.

48.

Rintoul RC, Ritchie AJ, Edwards JG, et al. Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial. Lancet. 2014;384:1118–27.

49.

Tan C, Sedrakyan A, Browne J, Swift S, Treasure T. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J Cardiothorac Surg. 2006;29:829–38.

Title: Surgery for mesothelioma: the evidence base and a pragmatic approach to surgical treatment
Authors: Vasudev Baburaya Pai
Kandadai Seshadri Rammohan
Tom Treasure
Publication date: 01-01-2018
Publisher: Springer Singapore
Published in: Indian Journal of Thoracic and Cardiovascular Surgery / Issue Special Issue 1/2018
Print ISSN: 0970-9134
Electronic ISSN: 0973-7723
DOI: https://doi.org/10.1007/s12055-017-0606-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Surgery for mesothelioma: the evidence base and a pragmatic approach to surgical treatment

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 1/2018

Immunotherapy for thoracic malignancies

Pleuropulmonary blastoma—a case report and review of literature

The state of the art and future directions of robotic-assisted thoracic surgery

Surgery for lung cancer—the Indian scenario

Sleeve lobectomy for lung cancer

Novel hybrid approaches for superior sulcus tumors